All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ2657 | Anti-SMPD2 (CBXS-4465) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4465 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ2658 | Anti-SMPD2 (CBXS-0573) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0573 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ6081 | Anti-SMPD2 (CBXS-4465) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-4465 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ6082 | Anti-SMPD2 (CBXS-0573) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXS-0573 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2066 | Anti-SMPD2 (CBWJN-1680) h(41BB-CD3ζ) CAR, pCDCAR1 | CBWJN-1680 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ4358 | Anti-SMPD2 (CBWJN-1680) h(CD28-CD3ζ) CAR, pCDCAR1 | CBWJN-1680 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-0320ZP2035 | Anti-SMPD2 (DS3344AB) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | DS3344AB | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP2036 | Anti-SMPD2 (DS3344AB) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | DS3344AB | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP2037 | Anti-SMPD2 (4A10) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 4A10 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP2038 | Anti-SMPD2 (4A10) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 4A10 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION